Asparaginase is an integral component of pediatric acute lymphoblastic leukemia (ALL) chemotherapy regimens and is known to be associated with improved long-term outcomes and survival [1,2]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.